MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma

Abstract Sebaceous gland carcinoma (SGC) is a rare, but life-threatening condition with a predilection for the periocular region. Eyelid SGC can be broadly categorised into two subtypes, namely either nodular or pagetoid with the latter being more aggressive and requiring radical excision to save li...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: John C. Bladen, Jun Wang, Ajanthah Sangaralingam, Mariya Moosajee, Caroline Fitchett, Claude Chelala, Michele Beaconsfield, Edel A. O’Toole, Michael P. Philpott, Daniel G. Ezra
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a8dbd7b7e4544abea6e78840cdc42587
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a8dbd7b7e4544abea6e78840cdc42587
record_format dspace
spelling oai:doaj.org-article:a8dbd7b7e4544abea6e78840cdc425872021-12-02T16:08:03ZMicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma10.1038/s41598-018-25900-z2045-2322https://doaj.org/article/a8dbd7b7e4544abea6e78840cdc425872018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25900-zhttps://doaj.org/toc/2045-2322Abstract Sebaceous gland carcinoma (SGC) is a rare, but life-threatening condition with a predilection for the periocular region. Eyelid SGC can be broadly categorised into two subtypes, namely either nodular or pagetoid with the latter being more aggressive and requiring radical excision to save life. We have identified key altered microRNAs (miRNA) involved in SGC shared by both subtypes, hsa-miR-34a-5p and hsa-miR-16-5p. However, their gene targets BCL2 and MYC were differentially expressed with both overexpressed in pagetoid but unchanged in nodular suggesting different modes of action of these two miRNAs on BCL/MYC expression. Hsa-miR-150p is nodular-specifically overexpressed, and its target ZEB1 was significantly downregulated in nodular SGC suggesting a tumour suppressor role. Invasive pagetoid subtype demonstrated specific overexpression of hsa-miR-205 and downregulation of hsa-miR-199a. Correspondingly, miRNA gene targets, EZH2 (by hsa-miR-205) and CD44 (by hsa-miR-199a), were both overexpressed in pagetoid SGC. CD44 has been identified as a potential cancer stem cell marker in head and neck squamous cell carcinoma and its overexpression in pagetoid cells represents a novel treatment target. Aberrant miRNAs and their gene targets have been identified in both SGC subtypes, paving the way for better molecular understanding of these tumours and identifying new treatment targets.John C. BladenJun WangAjanthah SangaralingamMariya MoosajeeCaroline FitchettClaude ChelalaMichele BeaconsfieldEdel A. O’TooleMichael P. PhilpottDaniel G. EzraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
John C. Bladen
Jun Wang
Ajanthah Sangaralingam
Mariya Moosajee
Caroline Fitchett
Claude Chelala
Michele Beaconsfield
Edel A. O’Toole
Michael P. Philpott
Daniel G. Ezra
MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma
description Abstract Sebaceous gland carcinoma (SGC) is a rare, but life-threatening condition with a predilection for the periocular region. Eyelid SGC can be broadly categorised into two subtypes, namely either nodular or pagetoid with the latter being more aggressive and requiring radical excision to save life. We have identified key altered microRNAs (miRNA) involved in SGC shared by both subtypes, hsa-miR-34a-5p and hsa-miR-16-5p. However, their gene targets BCL2 and MYC were differentially expressed with both overexpressed in pagetoid but unchanged in nodular suggesting different modes of action of these two miRNAs on BCL/MYC expression. Hsa-miR-150p is nodular-specifically overexpressed, and its target ZEB1 was significantly downregulated in nodular SGC suggesting a tumour suppressor role. Invasive pagetoid subtype demonstrated specific overexpression of hsa-miR-205 and downregulation of hsa-miR-199a. Correspondingly, miRNA gene targets, EZH2 (by hsa-miR-205) and CD44 (by hsa-miR-199a), were both overexpressed in pagetoid SGC. CD44 has been identified as a potential cancer stem cell marker in head and neck squamous cell carcinoma and its overexpression in pagetoid cells represents a novel treatment target. Aberrant miRNAs and their gene targets have been identified in both SGC subtypes, paving the way for better molecular understanding of these tumours and identifying new treatment targets.
format article
author John C. Bladen
Jun Wang
Ajanthah Sangaralingam
Mariya Moosajee
Caroline Fitchett
Claude Chelala
Michele Beaconsfield
Edel A. O’Toole
Michael P. Philpott
Daniel G. Ezra
author_facet John C. Bladen
Jun Wang
Ajanthah Sangaralingam
Mariya Moosajee
Caroline Fitchett
Claude Chelala
Michele Beaconsfield
Edel A. O’Toole
Michael P. Philpott
Daniel G. Ezra
author_sort John C. Bladen
title MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma
title_short MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma
title_full MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma
title_fullStr MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma
title_full_unstemmed MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma
title_sort microrna and transcriptome analysis in periocular sebaceous gland carcinoma
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/a8dbd7b7e4544abea6e78840cdc42587
work_keys_str_mv AT johncbladen micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
AT junwang micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
AT ajanthahsangaralingam micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
AT mariyamoosajee micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
AT carolinefitchett micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
AT claudechelala micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
AT michelebeaconsfield micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
AT edelaotoole micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
AT michaelpphilpott micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
AT danielgezra micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma
_version_ 1718384677092327424